Metabolic Disorders Completed Phase 2 Trials for Mipomersen (DB05528)

Back to Metabolic Disorders

Also known as: Metabolic Disorder / Metabolic disorder, unspecified / Metabolic disorder NOS / Generalized metabolic disorder (disorder) / Unspecified disorder of metabolism / Metabolic disease (disorder) / Metabolic Diseases

IndicationStatusPhase
DBCOND0035995 (Metabolic Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00477594
Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial HypercholesterolemiaTreatment
NCT00707746
Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant SubjectsTreatment
NCT00362180
Measure Liver Fat Content After ISIS 301012 (Mipomersen) AdministrationTreatment